Health is a strategic investment in human capital, not a cost, argues new report
Non-communicable diseases are placing an increasing strain on EU health systems, driving up costs and shortening life expectancy. A new report highlights that investing in prevention and treatment saves lives and yields significant economic benefits.
The report, written by R-Health Consult, and commissioned by the European Federation of Pharmaceutical Industries and Associations (EFPIA), outlines key findings on the economic and health benefits of investing in prevention, early detection, and treatment for five major non-communicable diseases (NCDs) – stroke, ischemic heart disease, type 2 diabetes, chronic obstructive pulmonary disease, and breast cancer – across all 27 EU member states.
It highlights the return on investment with…
